Go to KM Summary
ID Title Last Updated KM Node Tags
4795 Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Replacement Sequence of Drugs 26/04/2023
4797 Management of DR-TB ADR: Gastrointestinal Symptoms [Nausea and Vomiting] 26/04/2023
4569 Monitoring indicators related to ACF 26/04/2023
4803 Monitoring indicators related to TB Treatment 26/04/2023
4804 Monitoring indicators related to DR-TB Treatment 26/04/2023
4807 Monitoring indicator for TB Treatment outcome 26/04/2023
4809 Monitoring indicators related to Adherence 26/04/2023
4811 Monitoring of indicators related to TB-HIV 26/04/2023
4813 Monitoring of indicators related to TB-HIV Treatment 26/04/2023
4815 Monitoring of indicators related to TB-HIV prevention 26/04/2023
1643 NTEP Performance Indicator - Percentage of Target TB Notification Achieved 27/04/2023
1645 NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status 27/04/2023
1647 NTEP Performance Indicator - Percentage of TB Notified Patients with Universal Drug Susceptibility Testing (UDST) Done 27/04/2023
4817 Monitoring of Tobacco usage in TB patients 27/04/2023
4819 Monitoring of indicators related to DBT 27/04/2023
1659 NTEP Performance Indicator - Percentage of People Living with HIV (PLHIV) given INH Preventive Treatment (IPT) Against Total Eligible PLHIV 27/04/2023
4822 The Modernised Training System 27/04/2023
4823 Planning the training 27/04/2023
4824 The LMS- Swasth-eGurukul 27/04/2023
4825 Operationalising the training 27/04/2023
4826 Monitoring of training 27/04/2023
4827 Role and Responsibilities of key Stakeholders 27/04/2023
4834 General Process of Supervision 27/04/2023
4835 Pre-requisites for Supervision 27/04/2023
4836 Planning for Supervisory visit 27/04/2023
4837 Guidelines for Selection of area/health facility for Supervision 27/04/2023
4838 Modalities of Supervision 27/04/2023
4840 Supervisory tools and checklist 27/04/2023
832 Incentives for Private Providers and Informants 27/04/2023
4847 Incentives 27/04/2023